HomeStock ScreenerMakers Laboratories

Makers Laboratories Share Price | Makers Laboratories Stock Screener

MAKERSL Pharmaceuticals
Share Price BSE
₹176.45
▲ 20.85 (13.40%)
2026-05-20 00:00:00
As of May 20, 2026, the Makers Laboratories share price (BSE: MAKERSL) is ₹176.45, up 13.40% from the previous close, with shares trading between ₹158.00 and ₹186.70, and a 52-week range of ₹112.05–₹176.45. Check MAKERSL price range for the annual price range and momentum. Use the Makers Laboratories stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Makers Laboratories Market Cap ₹94.40 Cr.
MAKERSL P/E Ratio (TTM) 16.05
Makers Laboratories P/B Ratio 1.33
EPS (TTM) ₹12.70
Dividend Yield -
Debt to Equity 0.22
MAKERSL 52 Week High ₹176.45
Makers Laboratories 52 Week Low ₹112.05
Operating Margin 9.00%
Profit Margin 5.88%
MAKERSL Revenue (TTM) ₹34.00
EBITDA ₹3.00
Net Income ₹2.00
Total Assets ₹148.00
Total Equity ₹115.00

Makers Laboratories Share Price Chart

Screen Makers Laboratories share price with an interactive chart. Analyse MAKERSL price trends and volatility across different timeframes.

Makers Laboratories Company Profile - Fundamental Screener

Screen Makers Laboratories company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for MAKERSL shares.
Sector Healthcare
Industry Pharmaceuticals
Sub-Sector Pharmaceuticals
Segment E
ISIN INE987A01010

Makers Laboratories Balance Sheet Screener

Screen MAKERSL balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
Item 2025 2024 2023 2022 2021
Assets
Total Assets 148 161 152 144 136
Current Assets 68 70 63 63 61
Fixed Assets 74 87 85 68 71
Liabilities
Total Liabilities 0 0 0 0 0
Current Liabilities 12 20 15 13 17
Non-Current Liabilities 0 0 0 0 0
Shareholders' Equity
Total Equity 115 104 110 98 87
Share Capital 6 6 6 5 5
Reserves & Surplus 65 57 63 55 49

Makers Laboratories Income Statement Screener - Profit & Revenue Analysis

Screen Makers Laboratories income statement and profit fundamentals. Analyze MAKERSL quarterly results, revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Makers Laboratories share price evaluation.
Item 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar 2024-Jun 2024-Sept 2024-Dec 2023-Mar 2023-Jun 2023-Sept 2023-Dec 2022-Mar 2022-Jun 2022-Sept
Revenue 34 35 35 36 28 30 40 29 30 25 26 27 28 27 27
Expenses 31 32 32 32 27 29 27 26 28 25 25 26 25 25 25
EBITDA 3 3 3 5 1 1 13 2 2 0 1 1 3 1 3
Operating Profit % 9.00% 9.00% 7.00% 12.00% 3.00% 3.00% 7.00% 5.00% 6.00% -1.00% 1.00% 1.00% 7.00% 0.00% 6.00%
Depreciation 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Interest 0 0 0 0 1 1 0 0 0 0 1 1 0 0 1
Profit Before Tax 2 2 1 3 0 -1 11 1 1 -1 -1 -1 1 0 0
Tax 1 1 1 1 1 0 1 0 0 0 0 0 0 1 0
Net Profit 2 1 1 2 -1 -1 10 0 0 -2 -1 -1 1 -1 0
EPS -0.08 0.74 -0.20 1.59 -2.18 -1.67 14.94 -0.50 -0.43 -3.55 -2.27 -2.61 -1.24 -2.82 -1.00

Makers Laboratories Cash Flow Screener - Liquidity Fundamentals

Screen MAKERSL cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
Item 2025-March 2024-March 2023-March 2022-March 2021-March
Operating Activities -4 1 -9 19 0
Investing Activities 20 -7 1 -22 0
Financing Activities -16 6 6 0 0
Net Cash Flow 0 0 -2 -3 0

Makers Laboratories Shareholding Pattern Screener

See Makers Laboratories shareholding pattern with promoter, FII, and DII holdings. Check Makers Laboratories promoter holding and ownership changes for MAKERSL on TickJournal.
Item 2026-Mar 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar 2024-Jun 2024-Sept
Promoter Holding 61.27% 61.27% 61.27% 61.27% 61.27% 61.27% 61.27% 61.27%
FII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
DII Holding 0.39% 0.39% 0.39% 0.39% 0.39% 0.39% 0.39% 0.39%
Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 31.47% 30.90% 31.01% 30.98% 31.20% 29.93% 30.54% 30.86%
Other Holding 6.86% 7.43% 7.33% 7.36% 7.14% 8.40% 7.80% 7.48%
Shareholder Count 3,801 4,135 4,073 4,026 3,926 4,176 4,090 4,008

Makers Laboratories Share Dividend Screener - Share Yield Analysis

Check Makers Laboratories dividend history with payout and yield data. View Makers Laboratories dividend details including ex-dates and amounts for MAKERSL stock.
Period Dividend Per Share Dividend Yield
2026-March ₹0.00 0.00%
2025-March ₹0.00 0.00%
2024-March ₹0.00 0.00%
2023-March ₹0.00 0.00%
2022-March ₹0.00 0.00%
2021-March ₹0.00 0.00%
2020-March ₹0.00 0.00%
2019-March ₹1.00 3.50%
2018-March ₹1.00 1.98%
2017-March ₹1.00 1.42%

Makers Laboratories Stock Index Membership

See which indices include Makers Laboratories stock. Check MAKERSL index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Makers Laboratories is not part of any tracked indices.
Only major market indices are tracked in our system.

Makers Laboratories Market Events Screener - Corporate Actions

Get Makers Laboratories corporate actions including splits, bonuses, and buybacks. Check Makers Laboratories stock events that may affect MAKERSL share price.
Announcement Date Record Date Event Type Information Price Impact
2026-05-26 2026-05-26 Quarterly Result Announcement NA 8.77%
2026-02-10 2026-02-10 Quarterly Result Announcement NA 12.28%
2025-11-07 2025-11-07 Quarterly Result Announcement NA -2.41%
2025-08-08 2025-08-08 Annual General Meeting NA 3.91%
2025-08-08 2025-08-08 Quarterly Result Announcement NA 1.04%
2025-05-26 2025-05-26 Quarterly Result Announcement NA 17.74%
2025-01-29 2025-01-29 Quarterly Result Announcement NA -4.56%
2024-10-29 2024-10-29 Quarterly Result Announcement NA -4.57%
2024-08-06 2024-08-06 Annual General Meeting NA 25.61%
2022-03-30 2022-04-01 Rights 1:5 -2.95%

Makers Laboratories Competitors Screener - Peer Comparison

Screen MAKERSL competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sun Pharmaceutical 457,265 41.18 54,729 9.71% 10,980 67.81
Divis Laboratories 181,448 72.40 9,712 18.67% 2,191 66.76
Torrent Pharmaceuticals 148,703 65.64 11,539 6.99% 1,911 57.60
Cipla 115,206 29.94 27,712 -2.46% 3,783 68.41
Dr Reddys Laboratories 111,108 26.84 33,593 -0.44% 3,998 58.65
Mankind Pharma 103,024 57.32 12,744 20.90% 2,007 72.21
Lupin 102,944 19.41 27,488 19.98% 5,345 43.67
Zydus Life Science 99,728 20.25 23,511 18.55% 4,615 63.02
Aurobindo Pharma 87,149 25.19 32,346 9.43% 3,484 69.63
Laurus Labs 71,655 80.32 6,813 21.03% 884 80.55

Makers Laboratories Company Announcements - News Screener

Screen MAKERSL latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
Date Update Actions
2026-05-05 Board Meeting Intimation for Standalone And Consolidated Audited Financial Results For 4Th Quarter And Financial Year Ended 31St March 2026 -
2026-04-06 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-03-16 Closure of Trading Window -
2026-02-11 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-02-10 Standalone And Consolidated Financial Results For 3Rd Quarter And Nine Months Ended 31.12.2025 -
2026-02-10 Board Meeting Outcome for Standalone And Consolidated Financial Results For 3Rd Quarter And Nine Months Ended 31.12.2025 -
2026-01-21 Re-Lodgement Of Transfer Requests Report - November 2025 And December 2025 -
2026-01-21 Board Meeting Intimation for Standalone And Consolidated Financial Results For 3Rd Quarter And Nine Months Ended 31St December 2025 -
2026-01-08 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2025-12-22 Closure of Trading Window -
2025-11-18 Re-Lodgement Of Transfer Requests Of Physical Shares Report - October 2025 -
2025-11-10 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2025-11-07 Standalone And Consolidated Financial Results For Q2 And Half Year Ended 30.09.2025 -
2025-11-07 Board Meeting Outcome for Standalone And Consolidated Financial Results For Q2 And Half Year Ended 30.09.2025 -
2025-10-16 Board Meeting Intimation for Standalone And Consolidated Unaudited Financial Results For The 2Nd Quarter And Half Year Ended 30.09.2025 -
2025-10-10 Relodgement Of Transfer For Physical Shares - Sep 2025 -
2025-10-09 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2025-09-25 Closure of Trading Window -
2025-09-10 Relodgement Of Transfer Requests Of Physical Shares - July 2025 And August 2025 -
2025-09-10 Announcement under Regulation 30 (LODR)-Newspaper Publication -